Inventor
CHENG ZHANLING
CN10 patents
⚠️ This page may combine multiple inventors who share the name “CHENG ZHANLING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
9 patentsUS9845322B2Dec 19, 2017
Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE7 citations73
US11104674B2Aug 31, 2021
Tetrahydropyridopyrimidines for the treatment of HBV infection
HOFFMANN LA ROCHE2 citations72
US10336751B2Jul 2, 2019
Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE3 citations72
US10196391B2Feb 5, 2019
Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE2 citations72
US10150740B2Dec 11, 2018
6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE3 citations72
US11225482B2Jan 18, 2022
Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations62
US11124495B2Sep 21, 2021
Tetrahydroisoquinolines and terahydronaphthyridines for the treatment of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations62
US10968217B2Apr 6, 2021
Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations62
US10968218B2Apr 6, 2021
Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations51